Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
14/02/2024 17:27
Feb 14 (Reuters) - Theranexus SA ALTHX.PA :
* THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER
2023
AND PRESENTS AN UPDATE ON ITS PROGRAMS
* ON 31 DECEMBER 2023, TOTAL AVAILABLE FUNDS STOOD AT EUR4.9
M
(COMPARED WITH EUR6.0M ON 30 SEPTEMBER 2023
* COMPANY HAS SUFFICIENT CASH TO COVER ITS REQUIREMENTS
UNTIL
FEBRUARY 2025.
Source text for Eikon: ID:nACT84228
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease